ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Aveanna $458.8 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Privia Health $525.8 million IPO
We advised Privia Health on its IPO and Nasdaq listing
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
EDAP TMS $28 million follow-on offering
We advised the underwriters on the equity offering
Zai Lab $857.5 million offering of American depositary shares and ordinary shares
We advised Zai Lab on the concurrent offerings
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Lannett Company $350 million senior secured notes offering
We advised the initial purchasers on the high-yield notes offering
Recursion Pharmaceuticals $500 million IPO
We advised the underwriters on the IPO and Nasdaq listing